Materials & Resources » Chemicals | Porton Fine Chemicals Ltd.

Porton Fine Chemicals Ltd. | Cash Flow

Fiscal year is January-December. All values CNY Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
100,781.70
122,579.50
105,634.50
162,446.60
94,497.70
111,441.30
Depreciation, Depletion & Amortization
17,750.90
29,508.00
56,017.60
79,400.10
114,716.40
123,487.70
Other Funds
3,254.30
210,014.50
31,148.00
38,983.60
53,967.20
20,154.90
Funds from Operations
124,489.50
189,437.70
199,710.00
319,478.60
267,964.70
258,254.60
Changes in Working Capital
18,858.70
67,516.20
87,396.80
34,147.60
21,493.80
62,886.30
Net Operating Cash Flow
105,630.80
121,921.40
112,313.30
285,331.00
289,458.50
195,368.40
Capital Expenditures
186,264.50
336,956.10
424,033.90
188,573.50
157,168.80
Sale of Fixed Assets & Businesses
591.60
22.30
2,960.10
41,967.70
82.30
Purchase/Sale of Investments
-
-
88,702.10
15,300.00
-
Net Investing Cash Flow
184,521.20
340,706.70
504,841.50
162,768.40
317,692.80
Cash Dividends Paid - Total
-
10,137.00
12,644.00
16,866.50
25,491.80
Issuance/Reduction of Debt, Net
29,996.30
220,380.50
257,675.30
277,696.50
58,048.50
Net Financing Cash Flow
26,741.90
420,258.00
213,883.30
221,846.40
137,507.60
Net Change in Cash
52,262.50
197,511.30
181,639.20
352,563.20
168,864.50
Free Cash Flow
80,633.70
215,034.60
311,720.70
96,757.50
132,289.70
Deferred Taxes & Investment Tax Credit
1,192.40
3,020.30
2,420.70
4,877.70
1,243.00
3,170.70
Net Assets from Acquisitions
-
-
-
-
161,006.20
Other Sources
2,590.00
1,339.10
4,934.40
550.00
1,050.00
Exchange Rate Effect
114.00
3,961.40
2,994.20
8,154.20
3,122.70
Other Uses
1,438.30
5,112.10
-
1,412.60
650.00

About Porton Fine Chemicals

View Profile
Address
Fangzheng Avenue
Chongqing Chongqing 400714
China
Employees -
Website http://www.porton.cn
Updated 07/08/2019
Porton Pharma Solutions Ltd. engages in the research and development and manufacture of pharmaceutical products and active pharmaceutical ingredients. It offers anti-viral, anti-diabetic, anti-hypertensive, anti-cancer, analgesic, hypolipidemic, and antibacterial drug treatment. The company was founded on July 7, 2005 and is headquartered in Chongqing, China.